The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical Optics Array IOL was launched.
Starting in 1980, 3M Vison Care pioneered the application of diffractive optics to presbyopia-correcting IOLs. 3M Vision Care was divested to Alcon in the early 1990s, and further optical development resulted in the Alcon ReSTOR diffractive IOL family, which has today further evolved into the market-leading PanOptix trifocal presbyopia-correcting IOL. Advanced Medical Optics later acquired diffractive presbyopia-correcting IOL technology from Pharmacia, and